Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Internal Medicine

Surgery

Cancer Research

Radiation

Show all topics

DOI

10.1016/s0140-6736(20)30932-6

License

CC-BY

Other Formats

PDF